UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical cancer research, ISSN 1078-0432, 03/2018, Volume 24, Issue 5, pp. 1038 - 1047
Life Sciences & Biomedicine | Oncology | Science & Technology | Smoking - adverse effects | Lung Neoplasms - drug therapy | Prognosis | Prospective Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Tumor Suppressor Protein p53 - genetics | Young Adult | Adenocarcinoma of Lung - mortality | DNA Mutational Analysis | Adenocarcinoma of Lung - drug therapy | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacology | Biomarkers, Tumor - antagonists & inhibitors | Molecular Targeted Therapy - methods | Lung Neoplasms - genetics | Adenocarcinoma of Lung - etiology | Carcinogenesis - genetics | Treatment Outcome | Smoking - epidemiology | Survival Analysis | Aged | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Mutation | Adenocarcinoma | Therapy | Epidermal growth factor receptors | p53 Protein | Lung cancer | Patients | Survival | ErbB-2 protein | Gene sequencing | Consortia | Alterations | Genotyping | Experimental design | Tumor suppressor genes | Smoking | Cancer | Index Medicus | mutation | TP53 | targetable | EGFR | lung adenocarcinoma
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2654 - 2663
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Tumors | Female genital diseases | Medical History Taking | Recurrence | Prospective Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - drug therapy | Case-Control Studies | Ovarian Neoplasms - genetics | Peritoneal Neoplasms - drug therapy | Neoplasm Grading | Fallopian Tube Neoplasms - genetics | Aged, 80 and over | Genes, BRCA2 | Germ-Line Mutation | Adult | Female | Genes, BRCA1 | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Carcinoma, Endometrioid - genetics | Kaplan-Meier Estimate | Mutation Rate | Treatment Outcome | Carcinoma, Endometrioid - drug therapy | Australia - epidemiology | Ovarian Neoplasms - epidemiology | Disease-Free Survival | Point Mutation | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Peritoneal Neoplasms - genetics | Carcinoma - genetics | Aged | Platinum Compounds - administration & dosage | Neoplasm Staging | Adenocarcinoma, Clear Cell - genetics | Adenocarcinoma, Clear Cell - drug therapy | Cohort Studies | Index Medicus | Original Reports | Gynecologic Cancer | Gync21 | Gync15
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2007, Volume 43, Issue 11, pp. 1713 - 1717
Hematology, Oncology and Palliative Medicine | Founder mutations | Genetic epidemiology | Incident cancers | Breast cancer | BRCA1 | Genetic testing | BRCA2 | Ovarian cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Tumors | Genetic Testing | Humans | Middle Aged | Mutation - genetics | Genetic Carrier Screening - methods | Incidence | Ovarian Neoplasms - epidemiology | Ovarian Neoplasms - genetics | Breast Neoplasms - genetics | Pedigree | Norway - epidemiology | Genes, BRCA2 | Adult | Female | Heterozygote | Aged | Genes, BRCA1 | Breast Neoplasms - epidemiology | Genetic research | Genetic aspects | Gene mutations | Epidemiology | Index Medicus
Journal Article
Journal of medical genetics, ISSN 0022-2593, 06/2010, Volume 47, Issue 6, pp. 421 - 428
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Fundamental and applied biological sciences. Psychology | General aspects. Genetic counseling | Medical genetics | Biological and medical sciences | Molecular and cellular biology | Genetics of eukaryotes. Biological and molecular evolution | Medical sciences | Colonic Neoplasms - genetics | Pancreatic Neoplasms - diagnosis | Humans | Middle Aged | Colonic Neoplasms - diagnosis | Family Health | Male | Neoplasms - diagnosis | Li-Fraumeni Syndrome - diagnosis | Genetic Testing - methods | Tumor Suppressor Protein p53 - genetics | Young Adult | Li-Fraumeni Syndrome - genetics | Netherlands | Neoplasms - genetics | DNA Mutational Analysis | Germ-Line Mutation | Adult | Female | Genetic Predisposition to Disease | Gene Frequency | Risk Factors | Genotype | Pancreatic Neoplasms - genetics | Phenotype | Gene mutations | DNA | Analysis | Physiological aspects | Genetic aspects | Research | Risk factors | Li-Fraumeni syndrome | Liver cancer | Brain cancer | Pancreatic cancer | Colorectal cancer | Melanoma | Breast cancer | Mutation | Age | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 11/2006, Volume 12, Issue 21, pp. 6494 - 6501
tyrosine kinase inhibitor | epidermal growth factor receptor | acquired resistance | lung adenocarcinoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Pneumology | Erlotinib Hydrochloride | Lung Neoplasms - genetics | Protein Structure, Tertiary | Amino Acid Sequence | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Humans | Molecular Sequence Data | Receptor, Epidermal Growth Factor - drug effects | Antineoplastic Agents - therapeutic use | Gene Dosage | Reverse Transcriptase Polymerase Chain Reaction | Adenocarcinoma - drug therapy | Receptor, Epidermal Growth Factor - chemistry | Neoplasm Metastasis - genetics | Drug Resistance, Neoplasm - genetics | In Situ Hybridization | DNA Mutational Analysis | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Adenocarcinoma - genetics | Mutation | Index Medicus
Journal Article
2016, ISBN 0128044683, 192
eBook
Journal of thoracic oncology, ISSN 1556-0864, 05/2015, Volume 10, Issue 5, pp. 768 - 777
FISH | Lung adenocarcinoma | Mutation | Genotyping | LCMC | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology | DNA Mutational Analysis - standards | Humans | Bone Neoplasms - secondary | Lung Neoplasms - pathology | Male | DNA Mutational Analysis - methods | Proto-Oncogene Proteins c-akt - genetics | MAP Kinase Kinase 1 - genetics | Anaplastic Lymphoma Kinase | Adrenal Gland Neoplasms - secondary | Female | Adenocarcinoma - genetics | Bone Neoplasms - genetics | Liver Neoplasms - secondary | Genes, ras - genetics | Lung Neoplasms - genetics | Liver Neoplasms - genetics | Genes, erbB-1 - genetics | Cooperative Behavior | Smoking - genetics | Continental Population Groups - genetics | Adenocarcinoma - secondary | Proto-Oncogene Proteins c-met - genetics | Phosphatidylinositol 3-Kinases - genetics | Class I Phosphatidylinositol 3-Kinases | Receptor Protein-Tyrosine Kinases - genetics | Proto-Oncogene Proteins B-raf - genetics | Gene Rearrangement | Genes, erbB-2 - genetics | Sex Factors | Neoplasm Staging | Adrenal Gland Neoplasms - genetics
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 06/2013, Volume 123, Issue 6, pp. 2434 - 2446
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Gene Duplication | Hemolysis | Immobilized Proteins - chemistry | Kidney - pathology | Complement C3 - metabolism | Humans | Middle Aged | Protein Multimerization | Complement C3b Inactivator Proteins - genetics | Complement C3b Inactivator Proteins - chemistry | Male | Sequence Analysis, DNA | Kidney Diseases - genetics | Complement System Proteins - metabolism | Complement C3b Inactivator Proteins - metabolism | Complement C3 - chemistry | Pedigree | Immobilized Proteins - metabolism | Protein Structure, Quaternary | Complement System Proteins - isolation & purification | Protein Binding | Female | Mutagenesis, Insertional | Child | Glomerulonephritis | Complement factor H | Gene mutations | Physiological aspects | Causes of | Genetic aspects | Research | Proteins | Competition | Plasma | Carbohydrates | Mutation | Crystal structure | Index Medicus | Abridged Index Medicus | Avidity
Journal Article
Muscle & nerve, ISSN 0148-639X, 08/2006, Volume 34, Issue 2, pp. 135 - 144
reading frame | Becker muscular dystrophy | mutation | dystrophin | Duchenne muscular dystrophy | Reading frame | Mutation | Dystrophin | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Errors of metabolism | Biological and medical sciences | Metabolic diseases | Medical sciences | Carbohydrates (enzymatic deficiencies). Glycogenosis | Diseases of striated muscles. Neuromuscular diseases | Phenotype | Gene Frequency | Humans | Databases, Genetic | Muscular Dystrophy, Duchenne - genetics | Mutation - genetics | Germany | Reading Frames - genetics | Index Medicus
Journal Article